Abstract
Platelet-activating factor (PAF) is a phospholipid mediator of inflammation and anaphylaxis released by a variety of cell types. This study demonstrates that PAF is among the most potent biological radioprotectors known. PAF (300 μg/kg) given subcutaneously (s.c.) to CD2F1 male mice 5–10 minutes before irradiation increased survival by a factor of 1.7. This radioprotective efficacy was eliminated or reduced when dexamethasone was administered within 24 h before irradiation, 2 h after irradiation, or by an earlier PAF treatment 1 h before an otherwise radioprotective PAF dose. Protection was also attenuated by pretreatment with the PAF-specific antagonist, U-66985. Therefore, protection may be mediated by direct action on PAF-specific receptors in combination with indirect systemic events initiated by receptor activation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Walden, T.L., Jr., and Farzaneh, N.K. Biochemistry of Ionizing Radiation, Raven Press, New York, 1990.
Walden, T.L., Jr. Ann NY Acad Sci 524: 431–433, 1988.
Steel, L.K., Walden, Jr., T.L., Hughes, H.N. and Jackson, W.E. Radiat Res 115: 605–608, 1989.
Walden, T.L., Jr., Patchen, M.L., and Snyder, S.L., Radiat. Res. 109: 440–448, 1987.
Landauer M.R., Davis, H.D., and Walden, Jr., T.L. In: Eicosanoids and Bioactive Lipids in Cancer and Radiation Injury, (Eds. K.V. Honn, L.J. Marnett, S. Nigam, and T. Walden, Jr.), Kluwer Press, New York, 1991, pp 183–188.
Snyder, F. Prag. Clin. Biol. Res. 282: 57–72, 1988.
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. Pharmacol Rev 39: 97–145, 1987.
Homma, H., Tokumura, A., and Hanahan, D.J. J. Biol. Chem. 262: 10582–10587, 1987.
Gomez, J., Bloom, J.W., Yamaura, H.I., and Halonen, M. Am. J. Respir. Cell Mol. Biol. 3: 259–264, 1990.
Myers, A.K., Robey, J.W., and Price, R.M. Br. J. Pharmacol. 99: 499–502, 1990.
Tsunoda, H. Prostaglandins Leukot. Essent. Fatty Acids 39: 291–294, 1990.
Murphy, T.M., Munoz, N.M., Moss, J., Blake, J.S., Mack, M.M., and Leff, A.M. J. Appl. Physiol. 66: 638–643, 1989.
Bernardini, R., Calogero, A.E., Ehrlich, Y.H., Brucke, T., Chrousos, G.P., and Gold, P.W. Endocrinol. 125: 1067–1073, 1989.
Steel, L.K., Hughes, H.N., and Walden, Jr., T.L. Int. J. Radiat. Biol. 53: 943–964, 1988.
Myers, A., Ramey, E., and Ramwell, P. Br. J. Pharmacol. 79: 595–598, 1983.
Dembinska-Kiec, A., Peskar, B.A., Muller, M.K., and Peskar, B.M. Prostaglandins 37: 69–91, 1989.
Caplan, M.S., Sun, X.M., and Hsueh, W. Gastroenterol. 99: 979–986, 1990.
Allalunis-Turner, M.J., Walden, T.L., and Sawich, C. Radiat. Res. 118: 581–586, 1989.
Finney, D.J. Statistical Method in Biological Assay, 3rd Ed., MacMillan, New York, 1978, pp. 349–390.
Giambaressi, L.I., and Walker, R.I. In: Textbook of Military Medicine, Chapter 11, Volume 1, Part 2, Nuclear, Biological, and Chemical Warfare. Section 2, Nuclear Warfare, (Eds. R.I. Walker and T.J. Cerveny), Army Surgeon General’s Office, Washington, D.C., 1989, pp 245–273.
Ziboh, V.A., Wong, T., Wu, M.C., and Yunnis, A.A. Cancer Res. 46: 600–603, 1986.
Luini, A.G., and Axelrod, J. Proc. Natl. Acad. Sci USA 82: 1012–1014, 1985.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Walden, T.L., Steel, L.K., Hughes, H.N. (1993). Radioprotective Efficacy of Platelet Activating Factor in Mice. In: Nigam, S., Honn, K.V., Marnett, L.J., Walden, T.L. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Developments in Oncology, vol 71. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3520-1_71
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3520-1_71
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6562-4
Online ISBN: 978-1-4615-3520-1
eBook Packages: Springer Book Archive